Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
65.13B
Market cap65.13B
Price-Earnings ratio
17.73
Price-Earnings ratio17.73
Dividend yield
Dividend yield
Average volume
24.85M
Average volume24.85M
High today
$45.08
High today$45.08
Low today
$43.75
Low today$43.75
Open price
$44.23
Open price$44.23
Volume
21.02M
Volume21.02M
52 Week high
$105.65
52 Week high$105.65
52 Week low
$42.20
52 Week low$42.20

Stock Snapshot

The current Boston Scientific(BSX) stock price is $44.95, with a market capitalization of 65.13B. The stock trades at a price-to-earnings (P/E) ratio of 17.73.

On 2026-09-22, Boston Scientific(BSX) stock traded between a low of $43.75 and a high of $45.08. Shares are currently priced at $44.95, which is +2.7% above the low and -0.3% below the high.

The Boston Scientific(BSX)'s current trading volume is 21.02M, compared to an average daily volume of 24.85M.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $105.65 at its peak.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $105.65 at its peak.

BSX News

Simply Wall St 3h
Is Software Recall Risk Altering The Investment Case For Boston Scientific Stock?

Boston Scientific issued voluntary Class II recalls for its LUX-Dx Insertable Cardiac Monitor server software worldwide after FDA enforcement reports highlighte...

Is Software Recall Risk Altering The Investment Case For Boston Scientific Stock?
TipRanks 1d
Option traders moderately bearish in Boston Scientific with shares down 0.38%

Option traders moderately bearish in Boston Scientific (BSX), with shares down 16c near $43.17. Options volume relatively light with 11k contracts traded and ca...

TipRanks 1d
Boston Scientific price target lowered to $65 from $85 at Oppenheimer

Oppenheimer analyst Suraj Kalia lowered the firm’s price target on Boston Scientific (BSX) to $65 from $85 and keeps an Outperform rating on the shares ahead of...

Analyst ratings

82%

of 33 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

More BSX News

Nasdaq 1d
New Strong Sell Stocks for September 21st

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: AGCO Corporation AGCO is an agricultural equipment manufacturing company. The Zacks...

New Strong Sell Stocks for September 21st
Simply Wall St 3d
Boston Scientific Stock Could Be A Bargain On Strong Cash Flow Views

has seen a sharp reset in its share price over the past year, which puts a fresh spotlight on whether today's valuation is still supported by the cash the busin...

Boston Scientific Stock Could Be A Bargain On Strong Cash Flow Views
TipRanks 4d
Trip.com, Boston Scientific, Lyft, WES, Magna Trending With Analysts

Analysts are intrested in these 5 stocks: ( (TCOM) ), ( (BSX) ), ( (LYFT) ), ( (WES) ) and ( (MGA) ). Here is a breakdown of their recent ratings and the ration...

TipRanks 4d
Boston Scientific Advances Eso-SPONGE Trial, Targeting GI Leak Treatment and New Growth

Boston Scientific (BSX) announced an update on their ongoing clinical study. Boston Scientific Corp. is launching a new multicenter trial called “A Prospective...

TipRanks 5d
Analyst Maintains Buy on Boston Scientific, Viewing Cyberattack Impact as Short-Lived Despite Trimmed Near-Term Forecasts

Analyst Josh Jennings of TD Cowen maintained a Buy rating on Boston Scientific, with a price target of $56.00. Josh Jennings has given his Buy rating due to a c...

Seeking Alpha 5d
Boston Scientific downgraded at Citi on increasing competition, cyberattack fallout

Citi downgraded Boston Scientific (BSX) to Neutral from Buy, saying that it is still contending with the aftermath of an August cyberattack, as well as increase...

Boston Scientific downgraded at Citi on increasing competition, cyberattack fallout

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.